Home > PS Ratio > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of FREDUN PHARMACEUTICALS is 1.00.

Share Price ₹1,055.8Aug 18,2025
Market Cap ₹496.2 Cr
Sales-TTM₹497.3 CrTTM-Standalone Results
Price/Sales1.00xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of FREDUN PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of FREDUN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹496.2 Cr] as on Aug 18,2025

(/) Sales [ ₹497.3 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 1.00x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay '1.00 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of FREDUN PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of FREDUN PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of FREDUN PHARMACEUTICALS


PS Ratio Performance Analysis for FREDUN PHARMACEUTICALS

- FREDUN PHARMACEUTICALS 's latest p/e ratio is 1.00x.

- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.17x.

- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 1.28x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 1.81x.

- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.41x.


How does FREDUN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
FREDUN PHARMACEUTICALS 497.31.00496.2
SUN PHARMACEUTICAL INDUSTRIES LTD53,777.17.28391,667.0
DIVIS LABORATORIES LTD9,652.016.96163,697.0
CIPLA LTD27,811.24.54126,365.0
TORRENT PHARMACEUTICALS LTD11,835.010.45123,639.0
DR REDDYS LABORATORIES LTD33,519.93.15105,479.0
MANKIND PHARMA LTD12,956.27.87101,942.0
ZYDUS LIFESCIENCES LTD23,607.74.2099,270.0
LUPIN LTD23,375.93.8589,954.1
AUROBINDO PHARMA LTD32,024.81.9863,307.4
ABBOTT INDIA LTD6,589.910.5269,333.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs FREDUN PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.00x
Max industry PS 16.96x
Median industry PS 4.54x
Average industry PS 6.53x



You may also like the below Video Courses